Hikma’s Olafsson Sees Benefits From Broad Injectables Portfolio

Lessens Impact As Products In Shortage Return To US Market

 
• By David Wallace
  
Eggs_Basket
Hikma is not putting all of its eggs in one basket with its US injectables portfolio • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business